Similarly, we also found that PGM1 was significantly highly expressed in malignant BLCA, and its high expression indicated a worse survival rate, demonstrating that it may be a potential biomarker for malignant progression of BLCA. Here, PGM1 is linked to bladder transitional cell carcinoma.